Although escape mechanisms could still develop in these patients, improved drug responses were observed when the tumour growth specifically relied on the activation of IGF signalling pathways as shown in patients with Ewing sarcoma [15]. This evidence concerns the gene IGF1 and Ewing sarcoma.